PROCEPT BioRobotics (PRCT) Capital Expenditures Growth (1y) (2021 - 2026)
PROCEPT BioRobotics (PRCT) Capital Expenditures Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.39 Bn | 174.10 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 128.38 Bn | 125.50 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 107.68 Bn | 98.46 Bn | 6.41 Bn | 6.32% |
| 4 | Boston Scientific | 67.98 Bn | 66.53 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 47.81 Bn | 44.13 Bn | 1.29 Bn | 15.89% |
| 6 | GE HealthCare Technologies | 28.53 Bn | 26.25 Bn | 1.98 Bn | 106.98% |
| 7 | Dexcom | 28.35 Bn | 27.24 Bn | 750.30 Mn | -11.95% |
| 8 | Smith & Nephew | 26.78 Bn | 26.20 Bn | - | - |
| 9 | Koninklijke Philips | 25.34 Bn | 22.21 Bn | 2.07 Bn | -47.73% |
| 10 | PROCEPT BioRobotics | 978.77 Mn | 733.13 Mn | 53.95 Mn | 109.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 109.94% |
| Dec 31, 2025 | 472.76% |
| Sep 30, 2025 | 196.76% |
| Jun 30, 2025 | 33.74% |
| Mar 31, 2025 | 148.30% |
| Dec 31, 2024 | 102.21% |
| Sep 30, 2024 | -151.28% |
| Jun 30, 2024 | -54.77% |
| Mar 31, 2024 | -89.53% |
| Dec 31, 2023 | -932.56% |
| Sep 30, 2023 | 281.77% |
| Jun 30, 2023 | 6,987.18% |
| Mar 31, 2023 | 1,421.08% |
| Dec 31, 2022 | 348.21% |
| Sep 30, 2022 | 5,923.08% |
| Jun 30, 2022 | -141.71% |
| Mar 31, 2022 | 800.00% |
| Dec 31, 2021 | 1,087.88% |